Latest 蘑菇影院 Health News Stories
Watch and Listen: Opioid Settlement Case Triggers Protests Outside the High Court
The Supreme Court heard arguments over whether the Sacklers, the family behind Purdue Pharma 鈥 which marketed OxyContin 鈥 could claim immunity from future lawsuits without claiming bankruptcy.
Colorado Says Drug Industry Blocked Its Canada Dreams 鈥 And Biden Hasn鈥檛 Helped
Colorado鈥檚 leaders had grand plans to import cheaper medicines from Canada, after the Trump administration issued rules in 2020 allowing states to try it. But officials in Denver say they鈥檝e been stymied by opposition from drugmakers 鈥 as well as the Biden administration鈥檚 inaction on the policy. That鈥檚 according to a Dec. 1 report we […]
Many Autoimmune Disease Patients Struggle With Diagnosis, Costs, Inattentive Care
Despite the prevalence of autoimmune conditions, like the thyroid disease Hashimoto鈥檚, sometimes finding help can prove frustrating as well as expensive. There are often no definitive diagnostic tests, so patients may rack up big bills as they search for confirmation of their condition and for treatment options.
Health Care Is Front and Center as DeSantis and Newsom Go Mano a Mano
Florida鈥檚 Republican Gov. Ron DeSantis and California鈥檚 Democratic Gov. Gavin Newsom will square off in a first-of-its-kind debate on Nov. 30. 蘑菇影院 Health News compared the political rivals鈥 health care positions, showing how their policies have helped 鈥 or hindered 鈥 the health of their states鈥 residents.
Evolving Overdose Crisis Shakes Previously Effective Treatments
The prevalence of synthetic drugs is undercutting a previously effective and widely embraced opioid use disorder treatment tactic. Now, the model pioneered in Vermont a decade ago and adopted at sites nationwide, especially in hard-to-reach rural areas, is being forced to evolve.
Journalists Delve Into Open Enrollment, School Nurse Shortages, and More
蘑菇影院 Health News and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here鈥檚 a collection of their appearances.
Beyond Insulin: Medi-Cal Expands Patient Access to Diabetes Supplies
California鈥檚 Medicaid program is making it easier for people with diabetes to obtain the supplies and equipment they need to manage their blood sugar, partly by relaxing preauthorization requirements that can cause life-threatening delays.
Biden Administration鈥檚 Limit on Drug Industry Middlemen Backfires, Pharmacists Say
A rule taking effect Jan. 1 was intended to stop one set of abuses by pharmacy benefit managers, or PBMs, but some pharmacists say it鈥檚 enabling these price brokers to simply do new things unfairly.
A New RSV Shot Could Help Protect Babies This Winter 鈥 If They Can Get It in Time
Supply problems, a high price tag, and bureaucratic obstacles are slowing the distribution of a therapy that can protect infants from the respiratory syncytial virus. That will leave them unnecessarily at risk of hospitalization this winter, pediatricians fear.
US to Cover HIV Prevention Drugs for Older Americans to Stem Spread of the Virus
The government has proposed that Medicare fully cover preexposure prophylaxis drugs that prevent HIV, a change that could help America catch up with nations in Europe and Africa that are on track to end new infections decades before the U.S. under its current approach.
Prevenci贸n del VIH: proponen que Medicare cubra PrEP para adultos mayores
Seg煤n el plan de la administraci贸n Biden, Medicare cubrir铆a el costo total de los medicamentos de profilaxis previa a la exposici贸n, que previenen la transmisi贸n del VIH.
An Arm and a Leg: John Green vs. Johnson & Johnson (Part 2)
The high price of lifesaving tuberculosis drugs makes them inaccessible to many who need them most. On this episode of 鈥淎n Arm and a Leg,鈥 hear how a decades-long global fight to reform drug patents is helping to lower the cost.
A New Era of Vaccines Leaves Old Questions About Prices Unanswered
The CDC鈥檚 RSV vaccination recommendations beg the question: How much should an immunization that will possibly be given to millions of Americans cost to be truly valuable?
蘑菇影院 Health News' 'What the Health?': The New Speaker鈥檚 (Limited) Record on Health
The House finally has a new speaker: Mike Johnson (R-La). He鈥檚 a relative newcomer who鈥檚 been a lower-level member of the House GOP leadership. And while he鈥檚 an outspoken opponent of abortion and same-sex marriage, his record on other health issues is scant. Meanwhile, the National Institutes of Health appears on track to be getting a new director, and Georgia鈥檚 Medicaid work requirement experiment is off to a very slow start. Alice Miranda Ollstein of Politico and Rachel Cohrs of Stat join 蘑菇影院 Health News鈥 Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Michael Cannon, director of health policy studies at the Cato Institute, a libertarian think tank.
Biden Pick to Lead NIH Finally Has Her Day, but Still Gets Caught Up in Drug Price Debate
Monica Bertagnolli, the president鈥檚 choice to head the National Institutes of Health, appeared before a Senate committee this week. Her confirmation has been held up by Sen. Bernie Sanders (I-Vt.), who has demanded President Joe Biden work more aggressively to lower prescription drug prices.
蘑菇影院 Health News' 'What the Health?': The Open Enrollment Mixing Bowl
Open enrollment for Medicare beneficiaries with private health plans began Oct. 15, to be followed Nov. 1 by open enrollment for Affordable Care Act plans. The selection for both is large 鈥 often too large to be navigated easily alone. And people who choose incorrectly can end up with unaffordable medical bills. Meanwhile, those on both sides of the abortion issue are looking to Ohio鈥檚 November ballot measure on abortion to see whether anti-abortion forces can break their losing streak in statewide ballot questions since the overturn of Roe v. Wade in 2022.
蘑菇影院 Health News' 'What the Health?': Health Funding in Question in a Speaker-Less Congress
A bitterly divided Congress managed to keep the federal government running for several more weeks, while House Republicans struggle 鈥 again 鈥 to choose a leader. Meanwhile, many people removed from state Medicaid rolls are not finding their way to Affordable Care Act insurance, and a major investigation by The Washington Post attributes the decline in U.S. life expectancy to more than covid-19 and opioids. Lauren Weber of The Washington Post, Victoria Knight of Axios, and Sarah Karlin-Smith of the Pink Sheet join 蘑菇影院 Health News chief Washington correspondent Julie Rovner to discuss these issues and more. Also this week, Rovner interviews physician-author-playwright Samuel Shem about 鈥淥ur Hospital,鈥 his new novel about the health workforce in the age of covid.
An Arm and a Leg: John Green vs. Johnson & Johnson (Part 1)
Pharmaceutical patents can drive up the costs of lifesaving medications. Hear what author and YouTube star John Green is doing to make tuberculosis drugs more accessible to the people who need them most.
Trump Misplaced Blame When He Said Drug Shortages Were Biden鈥檚 Fault
Former President Donald Trump, who鈥檚 running for another term in the White House, recently blamed drug shortages on his successor, President Joe Biden. Our findings don鈥檛 align with Trump鈥檚 claims; by some measures, drug shortages increased more on Trump鈥檚 watch than on Biden鈥檚.
Florida Foster Kids Are Given Powerful Medications, but Feds Find State Oversight Lacking
A report by the U.S. Department of Health and Human Services raises troubling questions about the use of powerful medications within Florida鈥檚 child welfare system and the risk of overdoses or dangerous side effects if children are given the wrong combination of drugs.
